Affiliation:
1. Kazan State Medical University
Abstract
Introduction. Diagnosis, treatment and prevention of respiratory infections in the practice of a pediatrician occupy one of the leading places. Currently, much attention is paid to various links in the pathogenesis of viral respiratory diseases. Among them, particular importance is attached to the system of antioxidant defense and cytokine regulation of inflammation. It is important to study the effect of various drugs on these links of pathogenesis in order to increase the clinical effectiveness of therapeutic methods.Aim. To evaluate the clinical efficacy and impact on lipid peroxidation of Kagocel® in the treatment of respiratory viral infections in children.Materials and methods. An observational study was conducted involving 124 children aged 6 to 15 years with manifestations of a respiratory viral infection who received symptomatic treatment, of which 89 children additionally took antiviral therapy with Kagocel®.Results. Along with the good tolerance of Kagocel® and the absence of side effects in children on the background of its use, a significantly shorter period of regression of the main clinical symptoms of acute respiratory infection was shown. It was noted that in children taking Kagocel® on the 3rd-5th day of therapy, there is an increase in the total antioxidant activity of blood plasma and a decrease in the level of malondialdehyde compared with patients who did not take the drug, which demonstrates the antioxidant effects of Kagocel®, which certainly have a positive effect on the character course of the healing process.Conclusion. Kagocel® has been shown to have high clinical efficacy and antioxidant effects.
Reference18 articles.
1. Baranov A.A., Namazova-Baranova L.S., Lobzin Yu.V., Tatochenko V.K., Uskov A.N., Kulichenko T.V. et al. Acute Respiratory Viral Infection in Children: Modern Approaches to Diagnosis and Treatment. Pediatric Pharmacology. 2017;14(2):100-108. (In Russ.) https://doi.org/10.15690/pf.v14i2.1724.
2. Safiullin T.R., Vahitov H.M., Eremeeva O.N., Loskutova E.V., Vorontsova I.A., Ibragimova Zh.R., Samoilova N.V. Etiology of respiratory diseases in children: modern diagnostic capabilities. Medical Newsletter of Vyatka. 2018;2(58):57-65. (In Russ.) Available at: file://Users/Start/Downloads/28-28-PB.pdf.
3. Simbirtsev A.S. Immunopharmacological aspects of the cytokine system. Bulletin of Siberian Medicine. 2019;18(1):84-95. (In Russ.) https://doi.org/10.20538/1682-0363-2019-1-84-95.
4. Vasilevsky I.V., Lavrinenko A.V. Clinico-pharmacological rationale for the use of interferons in clinical practice. Healthcare. 2016;(7):51-63. (In Russ.) Available at: https://www.zdrav.by/farmakologiya/kliniko-farmakologicheskoe-obosnovanie-primeneniya-interferonov-v-klinicheskoj-praktike/.
5. Sokolova T.M., Ershov F.I. RNA-interference and the system of interferon. Citokiny i Vospalenie. 2011;10(4):11-20. (In Russ.) Available at: https://www.citokines.ru/2011/4/Art2.php.